Subscribe to stay informed!
Malvern-based Fujirebio Diagnostics has received marketing authorization from the FDA for its diagnostic test for Alzheimer’s disease, writes John George for the Philadelphia…
Obamacare’s new-in-2013 medical device tax is killing the potential for new jobs at medical device developers like Malvern’s Fujirebio Diagnostics, according…
Before we send you to this site, please subscribe to our daily newsletter.